EXZILOR TABLET contains Flupenthixol and Melitracen, which belong to the group of medicines called antipsychotics and tricyclic antidepressants. It is used in the management of anxiety, depression, and asthenia. It is also used to manage neurasthenia, psychogenic depression, masked depression, menopausal depression, dysphoria, depression in alcoholics and drug addicts, and psychosomatic affections that are accompanied by anxiety and apathy with depressive neuroses.
Anxiety is a feeling of fear, dread, and uneasiness that is generally characterised by symptoms such as a fast heart rate, rapid breathing, sweating, and tiredness. Depression is a mood disorder that causes a persistent feeling of sadness and loss of interest, leading to emotional and physical problems accompanied by symptoms such as changes in sleep, appetite, and daily behaviour.
Avoid taking EXZILOR TABLET if you are a manic patient and/or have heart diseases such as circulatory collapse, a depressed level of consciousness, blood disorders, or hereditary problems of galactose (sugar) intolerance. Before taking EXZILOR TABLET, inform your doctor if you have convulsions, organic brain syndrome, a history of suicide-related events, diabetes, planned surgeries, or reduced liver or kidney function.
EXZILOR TABLET is not recommended for use by pregnant women unless recommended by your doctor. Because it can pass through breast milk, it should be used with caution in breastfeeding women. EXZILOR TABLET is not recommended for use in children and adolescents (below 18 years of age). The most common symptoms of taking EXZILOR TABLET are sleeplessness, restlessness, agitation, dizziness, tremors (involuntary movements of muscles), dry mouth, and constipation. Consult your doctor if any of the symptoms are worse.
No content available
